A. J. Ali, “Cardiovascular Benefits and Pharmacological Mechanisms of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus: A Narrative Review”, IJBR, vol. 4, no. 2, pp. 47–57, Feb. 2026, doi: 10.70749/ijbr.v4i2.2909.